Oscient Pharmaceuticals (NASDAQ: OSCI) announced it will discontinue sales force promotion of its two products: ANTARA (fenofibrate) capsules, a cardiovascular ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE